FFF Enterprises Selects TraceLink to Meet DSCSA Deadlines, Protect Patients
TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, announced today that FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, has chosen the TraceLink Life Sciences Cloud to further its ongoing commitment to supply chain and patient safety. FFF Enterprises, which has operated counterfeit-free for the past 27 years, will utilize the unique native cloud-based applications from TraceLink to meet the complex requirements for the US Drug Supply Chain Security Act (DSCSA) deadline of January 1, 2015.
“For more than two-and-a-half decades, our focus has been to make sure that patient safety is not compromised across the supply chain. Investing in solutions from TraceLink not only guarantees that we’ll be ready to meet the upcoming DSCSA deadline, it demonstrates our proactive commitment to raise pharmaceutical industry standards and provide the safest and most secure supply chain possible, which has resulted in more than 9,600 counterfeit-free days,” said Patrick M. Schmidt, CEO at FFF Enterprises. “By leveraging the thousands of companies already configured on the TraceLink Network, a single link to the Life Sciences Cloud ensures that we can quickly and securely connect to our large and diversified trading network for on-time DSCSA compliance."
The DSCSA regulation, which begins to phase in on January 1, 2015, provides a national policy for combatting counterfeiting, theft, and diversion in the US pharmaceutical supply chain. The new law establishes extensive new regulations providing for the tracing and verification of products and transactions across all changes of ownership from manufacturer to dispenser. As a result, leading wholesale distributors like FFF Enterprises face complicated data management, data exchange and business process challenges that will impact their operations and all of their supplier and trading partner relationships.
“FFF Enterprises has a long-standing commitment to ensure a safe, secure drug supply chain for its customers," said Shabbir Dahod, president and CEO of TraceLink. “TraceLink delivers the only mature, field-tested platform that demonstrably minimizes the cost, risk and time in meeting the impending DSCSA – and will help FFF Enterprises to continue delivering the highest degree of supply chain safety that its customers have come to expect.”
The TraceLink Life Sciences Cloud: A Unique Platform for Ensured DSCSA Compliance
TraceLink enables manufacturers, wholesalers and pharmacies to instantly link to tens of thousands of trading partners that are already connected to the Life Sciences Cloud. In fact, companies who are considering TraceLink to help them meet January 1, 2015 DSCSA deadlines typically find that over 90% of the suppliers and trading partners they do business with are already on the TraceLink network. A single connection to the Life Sciences Cloud delivers end-to-end DSCSA compliance for all DSCSA requirements of the largest pharmaceutical company or the smallest pharmacy across all supplier and trading partner relationships.
Built on the Amazon Web Services global cloud infrastructure as a native cloud application platform, the TraceLink Life Science Cloud delivers complete end-to-end DSCSA compliance for all Tracing, Verification and Serialization requirements. TraceLink customers gain:
- A full Transaction History Management System including integrated tracing and verification support for both lot-level and serialized products in a fully indexed compliance document repository
- Extensive interoperability across the entire supply network with support for HDMA ASN, GS1 EPCIS and secure web portal
- Extensive operational use case support for managing lot-level products during receiving, putaway, pick-pack-ship operations
- Complete management of all DSCSA compliance scenarios including direct purchase and non-direct purchase, drop shipment, saleable returns and other special TH/TI/TS requirements
For more information about meeting critical DSCSA compliance deadlines or building a flexible global serialization, track and trace, and reporting platform for China to Brazil, visit www.tracelink.com.
About FFF Enterprises
Temecula-based FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other specialty pharmaceuticals and biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 27th year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regard to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF’s commitment to Guaranteed Channel Integrity™, ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF’s proprietary systems, Verified Inventory Program-Consignment (VIPc)™, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel, and FFF’s MyFluVaccine and VaxAmerica are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers.
TraceLink protects patients and enables health for companies across the global Life Sciences supply network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is trusted by fourteen of the top-20 pharmaceutical companies and businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark’s mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at firstmarkcap.com and @FirstMarkCap.